Trial Profile
A phase II evaluation of tamoxifen and goserelin in advanced ovarian cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2005
Price :
$35
*
At a glance
- Drugs Goserelin (Primary) ; Tamoxifen (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 03 Aug 2005 New trial record.